Aehr Test Systems
AEHR
$36.46
$0.651.82%
| Weiss Ratings | AEHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Excellent | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | A | |||
| Rating Factors | AEHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Excellent | |||
| Efficiency Index | Good | |||
| Solvency Index | Excellent | |||
| Total Return Index | Excellent | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | AEHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 2.62 | |||
| Price History | AEHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 3.17% | |||
| 30-Day Total Return | 74.78% | |||
| 60-Day Total Return | 75.80% | |||
| 90-Day Total Return | 157.30% | |||
| Year to Date Total Return | 98.26% | |||
| 1-Year Total Return | 199.10% | |||
| 2-Year Total Return | 1,329.80% | |||
| 3-Year Total Return | 1,713.93% | |||
| 5-Year Total Return | 1,478.35% | |||
| 52-Week High % Change | -3.99% | |||
| 52-Week Low % Change | 433.68% | |||
| Price | AEHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $37.30 | |||
| 52-Week Low Price | $6.71 | |||
| 52-Week Low Price (Date) | Jul 05, 2022 | |||
| 52-Week High Price (Date) | Feb 03, 2023 | |||
| Valuation | AEHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | $994.07M | |||
| Enterprise Value | 958.10M | |||
| Price/Earnings (TTM) | 82.25 | |||
| Earnings Per Share (TTM) | 0.44 | |||
| Earnings Per Share Growth | 878.43% | |||
| Price/Earnings To Growth | 0.09 | |||
| Price/Sales (TTM) | 17.06 | |||
| Price/Book (Q) | 17.52 | |||
| Enterprise Value/Revenue (TTM) | 15.69 | |||
| Price | $36.46 | |||
| Enterprise Value/EBITDA (TTM) | 77.47 | |||
| Enterprise Value/EBIT | 79.72 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | AEHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 29.080M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | AEHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 510 623 9400 | |||
| Address | 400 Kato Terrace Fremont, CA 94539 | |||
| Website | www.aehr.com | |||
| Country | United States | |||
| Year Founded | 1977 | |||
| Profitability | AEHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 19.68% | |||
| Profit Margin | 20.22% | |||
| Management Effectiveness | AEHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 11.95% | |||
| Return on Equity | 25.33% | |||
| Income Statement | AEHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | $61.06M | |||
| Total Revenue (TTM) | $61.06M | |||
| Revenue Per Share | $2.10 | |||
| Gross Profit (TTM) | $29.26M | |||
| EBITDA (TTM) | $12.37M | |||
| EBIT (TTM) | $12.02M | |||
| Net Income (TTM) | $12.35M | |||
| Net Income Avl. to Common (TTM) | $12.35M | |||
| Total Revenue Growth (Q YOY) | 54.15% | |||
| Earnings Growth (Q YOY) | 419.53% | |||
| EPS Diluted (TTM) | $0.44 | |||
| EPS Diluted Growth (Q YOY) | 374.45% | |||
| Balance Sheet | AEHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | $36.58M | |||
| Cash Per Share (Q) | $1.26 | |||
| Total Current Assets (Q) | $65.54M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | $56.67M | |||
| Current Ratio (Q) | 6.099 | |||
| Book Value Per Share (Q) | $2.04 | |||
| Total Assets (Q) | $67.54M | |||
| Total Current Liabilities (Q) | $10.75M | |||
| Total Debt (Q) | $616.00K | |||
| Total Liabilities (Q) | $10.88M | |||
| Total Common Equity (Q) | $56.67M | |||
| Cash Flow | AEHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -$18.04M | |||
| Cash from Financing (TTM) | $283.00K | |||
| Net Change in Cash (TTM) | -$16.16M | |||
| Levered Free Cash Flow (TTM) | -$2.81M | |||
| Cash from Operations (TTM) | $1.56M | |||
